UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort

The American journal of gastroenterology, 2014-10, Vol.109 (10), p.1675-1683

2014

Volltextzugriff (PDF)

Risk factors for biliary tract carcinogenesis

Annals of oncology, 1999, Vol.10, p.308-311

CHAPMAN, R. W

1999

Volltextzugriff (PDF)

Systematic review: management options for primary sclerosing cholangitis and its variant forms – IgG4‐associated cholangitis and overlap with autoimmune hepatitis

Alimentary pharmacology & therapeutics, 2011-06, Vol.33 (12), p.1273-1291

2011

Volltextzugriff (PDF)

Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging

Alimentary pharmacology & therapeutics, 2016-11, Vol.44 (9), p.936-945

2016

Volltextzugriff (PDF)

PSC, AIH and overlap syndrome in inflammatory bowel disease

Clinics and research in hepatology and gastroenterology, 2012-10, Vol.36 (5), p.420-436

2012

Volltextzugriff (PDF)

Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis

Gut, 2002-11, Vol.51 (5), p.731-735

2002

Volltextzugriff (PDF)

Editorial: vancomycin – a promising option for the treatment of primary sclerosing cholangitis?

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (9), p.1321-1322

Chapman, R. W.

2018

Volltextzugriff (PDF)

Antibodies to SS‐A/Ro‐52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis

Alimentary pharmacology & therapeutics, 2007-09, Vol.26 (6), p.831-838

2007

Volltextzugriff (PDF)

Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome

The American journal of gastroenterology, 2013-09, Vol.108 (9), p.1508-1515

2013

Volltextzugriff (PDF)

Review article: current management of primary sclerosing cholangitis

Alimentary pharmacology & therapeutics, 2005-04, Vol.21 (8), p.933-948

2005

Volltextzugriff (PDF)

Fatigue in patients with primary sclerosing cholangitis

Scandinavian journal of gastroenterology, 2004-10, Vol.39 (10), p.961-968

2004

Volltextzugriff (PDF)

Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim‐like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis

Alimentary pharmacology & therapeutics, 2006-12, Vol.24 (11‐12), p.1575-1583

2006

Volltextzugriff (PDF)

Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?

Gut, 2001-03, Vol.48 (3), p.430-434

2001

Volltextzugriff (PDF)

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

Gastroenterology (New York, N.Y. 1943), 2001-10, Vol.121 (4), p.900-907

2001

Volltextzugriff (PDF)

Chemoprevention and screening in primary sclerosing cholangitis

Postgraduate medical journal, 2008-05, Vol.84 (991), p.228-237

2008

Volltextzugriff (PDF)

CXCR2 antagonists for the treatment of pulmonary disease

Pharmacology & therapeutics (Oxford), 2009-01, Vol.121 (1), p.55-68

2009

Volltextzugriff (PDF)

Association of the tumour necrosis factor α −308 but not the interleukin 10 −627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis

Gut, 2001-08, Vol.49 (2), p.288-294

2001

Volltextzugriff (PDF)

Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC

Alimentary pharmacology & therapeutics, 2015-01, Vol.41 (1), p.149-151

2015

Volltextzugriff (PDF)

Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study

Gut, 2002-10, Vol.51 (4), p.567-573

2002

Volltextzugriff (PDF)

A rare cause of colonic thickening and lymphadenopathy

Gut, 2017-01, Vol.66 (1), p.78-78

2017

Volltextzugriff (PDF)

A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease

Journal of Crohn's and colitis, 2012-03, Vol.6 (2), p.174-181

2012

Volltextzugriff (PDF)

Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double‐blind, randomized, placebo‐controlled trial

Alimentary pharmacology & therapeutics, 2002-06, Vol.16 (6), p.1187-1195

2002

Volltextzugriff (PDF)

Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass

Gut, 1996-03, Vol.38 (3), p.384-389

1996

Volltextzugriff (PDF)

New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-25

The Journal of immunology (1950), 2002-07, Vol.169 (1), p.443-453

2002

Volltextzugriff (PDF)

Inhibition of experimental acute pulmonary inflammation by pirfenidone

Pulmonary pharmacology & therapeutics, 2003-01, Vol.16 (4), p.207-214

2003

Volltextzugriff (PDF)

1 – 25 von 1.629

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.513)
Mit Volltextzugriff
(1.237)

Publikationsform

Sprache

Englisch
(1.628)
Spanisch
(1)
Polnisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort

Risk factors for biliary tract carcinogenesis

Systematic review: management options for primary sclerosing cholangitis and its variant forms – IgG4‐associated cholangitis and overlap with autoimmune hepatitis

Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging

PSC, AIH and overlap syndrome in inflammatory bowel disease

Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis

Editorial: vancomycin – a promising option for the treatment of primary sclerosing cholangitis?

Antibodies to SS‐A/Ro‐52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis

Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome

Review article: current management of primary sclerosing cholangitis

Fatigue in patients with primary sclerosing cholangitis

Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim‐like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis

Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

Chemoprevention and screening in primary sclerosing cholangitis

CXCR2 antagonists for the treatment of pulmonary disease

Association of the tumour necrosis factor α −308 but not the interleukin 10 −627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis

Editorial: further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC

Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study

A rare cause of colonic thickening and lymphadenopathy

A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease

Alverine citrate fails to relieve the symptoms of irritable bowel syndrome: results of a double‐blind, randomized, placebo‐controlled trial

Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass

New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-25

Inhibition of experimental acute pulmonary inflammation by pirfenidone

Aktive Filter

Suchergebnisse filtern